Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Malwina Holownia-Voloskova"'
Autor:
Rita Daubner-Bendes, Sándor Kovács, Maciej Niewada, Mirjana Huic, Michael Drummond, Oriana Ciani, Carl Rudolf Blankart, Olena Mandrik, Aleksandra Torbica, John Yfantopoulos, Guenka Petrova, Malwina Holownia-Voloskova, Rod S. Taylor, Maiwenn Al, Oresta Piniazhko, László Lorenzovici, Rosanna Tarricone, Antal Zemplényi, Zoltán Kaló
Publikováno v:
Frontiers in Public Health, Vol 8 (2021)
Objectives: Methodological challenges in the evaluation of medical devices (MDs) may be different for early and late technology adopter countries, as well as the potential health technology assessment (HTA) solutions to tackle them. This study aims t
Externí odkaz:
https://doaj.org/article/2fcee49fd2324bddad50714aa9e98040
Autor:
Marcin Czech, Aleksandra Baran-Kooiker, Kagan Atikeler, Maria Demirtshyan, Kamilla Gaitova, Malwina Holownia-Voloskova, Adina Turcu-Stiolica, Coen Kooiker, Oresta Piniazhko, Natella Konstandyan, Olha Zalis'ka, Jolanta Sykut-Cegielska
Publikováno v:
Frontiers in Public Health, Vol 7 (2020)
Background: Despite international initiatives on collaboration within the field of rare diseases, patient access to orphan medicinal products (OMPs) and healthcare services differ greatly between countries. This study aimed to create a comprehensive
Externí odkaz:
https://doaj.org/article/54fbf934650d4dfaa00a5bc3825e3426
Publikováno v:
HEALTH CARE OF THE RUSSIAN FEDERATION. 66:473-477
Introduction. The change in the classical etiological paradigm of hepatocellular carcinoma has led to the fact that non-alcoholic fatty liver disease is now the fastest growing cause of hepatocellular carcinoma in the world. Purpose. To study the ran
Publikováno v:
Annals of the Russian academy of medical sciences. 77:62-69
Background. Systematic research work on the assessment of medicines consumption allows timely identification of effective and problematic aspects of the existing system of preferential medicines provision, allowing to regulate the optimality of its f
Autor:
Ekaterina B. Kornilova, Evgenii A. Luchinin, Dmitriy A. Roslik, Elena S. Ar’kova, Malwina Holownia-Voloskova, Aleksandr A. Zavyalov
Publikováno v:
Health Care of the Russian Federation. 64:318-323
Introduction. Such medical technology like a direct antiviral drugs for treatment for chronic hepatitis C (CHC) remains inaccessible due to high absolute cost for health care systems, lack of assessment in specific region of Russian Federation and co
Publikováno v:
Problems of Social Hygiene Public Health and History of Medicine. 29
Introduction Liver cirrhosis is a major but preventable cause of health loss worldwide. The era of «big data» allows us to evaluate this nosology in a new format. Purpose Evaluation of the registered population of patients with cirrhosis of the liv
Autor:
Marcin Czech, Adina Turcu-Stiolica, K. Atikeler, Coen Kooiker, Malwina Holownia-Voloskova, Aleksandra Baran-Kooiker, Kamilla Gaitova, Oresta Piniazhko
Publikováno v:
Acta Poloniae Pharmaceutica - Drug Research. 76:581-598
Autor:
Konstantin A. Kokushkin, Tatiana N. Ermolaeva, Pavel A. Vorobiev, Maxim Grinin, Maria V. Davydovskaya, Malwina Holownia-Voloskova
Publikováno v:
Value in Health Regional Issues. 16:106-111
Objectives To describe characteristics of the drug policy in Russia in terms of health technology assessment (HTA), registries of patients, pricing of drugs, cost-containment methods, and reimbursement of drugs. Methods The legal and regulatory frame
Publikováno v:
Postępy Biochemii.
Celem poniższej notki jest przybliżenie czytelnikom tematu współpracy w zakresie oceny technologii medycznych w krajach Unii Europejskiej (UE), obecnej sytuacji oraz przyszłych planowanych prac w tej dziedzinie. Komisja Europejska próbuje stwor
Publikováno v:
Value in Health. 23:S362-S363